Saroja Pharma Industries India Limited is primarily engaged in providing pharmaceutical services, focusing on the trade of Active Pharmaceutical Ingredients (API), Pharma Intermediates, and other chemical products used in human and veterinary medicine.

The company has recently transitioned from a private to a public limited entity, intending to leverage its new structure to access broader market opportunities and increase its investor base.

Saroja Pharma is planning a public issue of equity shares to raise capital, indicating a strategic intent to fuel further growth and expansion in the pharmaceutical sector.

The company has witnessed significant growth in its client base over the past two years, suggesting a strong market presence and demand for its offerings.

Founders Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble are focused on global integration and innovation, positioning the company as a reputable player in the global healthcare landscape.